Glyburide description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Glyburide

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

GLYBURIDE DESCRIPTION


Glyburide






CLINICAL PHARMACOLOGY

Actions





PHARMACOKINETICS






INDICATIONS & USAGE



GLYBURIDE CONTRAINDICATIONS






WARNINGS

SPECIAL WARNING ON INCREASED RISK OF CARDIOVASCULAR MORTALITY




PRECAUTIONS



General

Macrovascular Outcomes


Hypoglycemia


Loss of Control of Blood Glucose



Hemolytic Anemia


INFORMATION FOR PATIENTS




Physician Counseling Information for Patients


LABORATORY TESTS



DRUG INTERACTIONS






Metformin


CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY



PREGNANCY

Teratogenic Effects

Pregnancy category B



Nonteratogenic Effects


NURSING MOTHERS



PEDIATRIC USE



GERIATRIC USE




GLYBURIDE ADVERSE REACTIONS










OVERDOSAGE



DOSAGE & ADMINISTRATION





Usual Starting Dose


Transfer From Other Hypoglycemic Therapy Patients Receiving Other Oral Antidiabetic Therapy


Patients Receiving Insulin


Titration to Maintenance Dose




Concomitant Glyburide and Metformin Therapy



Maximum Dose


Dosage Interval


Specific Patient Populations



HOW SUPPLIED


























PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Glyburide



Glyburide



Glyburide

Glyburide TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-175(NDC:0093-8343)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
GLYBURIDE GLYBURIDE 2.5 mg

Inactive Ingredients

Ingredient Name Strength
cellulose, microcrystalline
STARCH, CORN
SODIUM STARCH GLYCOLATE TYPE A POTATO
SILICON DIOXIDE
MAGNESIUM STEARATE
FD&C YELLOW NO. 6

Product Characteristics

Color Size Imprint Code Shape
orange 8 mm N;343;2;5 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-175-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA074388 2011-04-18


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.